Denali therapeutics dnli
WebDNLI Stock 12 Months Forecast. Based on 12 Wall Street analysts offering 12 month price targets for Denali Therapeutics in the last 3 months. The average price target is $57.33 with a high forecast of $105.00 and a low forecast of $32.00. The average price target represents a 146.16% change from the last price of $23.29. WebApr 10, 2024 · Company Profile DNLI. Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development ...
Denali therapeutics dnli
Did you know?
WebApr 6, 2024 · Denali Therapeutics Inc. (NASDAQ:DNLI) announced its quarterly earnings data on Monday, February, 27th. The company reported ($0.75) EPS for the quarter, beating analysts' consensus estimates of … WebApr 10, 2024 · Denali Therapeutics (NASDAQ:DNLI) and CRISPR Therapeutics (NASDAQ:CRSP) are both mid-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst …
WebApr 6, 2024 · As of April 6, 2024, the average one-year price target for Denali Therapeutics is $60.88. The forecasts range from a low of $32.32 to a high of $110.25. The average price target represents an ... WebGet the latest Denali Therapeutics Inc (DNLI) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and …
WebJan 13, 2024 · SOUTH SAN FRANCISCO, Calif., Jan. 13, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to ... WebApr 14, 2024 · While Denali Therapeutics Inc. (NASDAQ:DNLI) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the share price falling 15% in the last quarter ...
WebApr 13, 2024 · Denali Therapeutics Inc. (NASDAQ:DNLI – Get Rating) gapped up before the market opened on Wednesday after Morgan Stanley raised their price target on the stock from $61.00 to $63.00.
WebGlobeNewswire. Oct-24-22 04:30PM. Denali Therapeutics Announces Closing of a $316 Million Public Offering, Including Full Exercise of Underwriters Option to Purchase … extended butt-pad for the shotgunWebDenali Therapeutics (DNLI) Gets a Buy from Morgan Stanley March 1, 2024TipRanks. Analysts Offer Insights on Healthcare Companies: Sarepta Therapeutics (SRPT), … extended busesWebFeb 27, 2024 · Get the latest Denali Therapeutics Inc. (DNLI) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. extended butterfly locsWebFind real-time DNLI - Denali Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. DNLI - Denali Therapeutics Inc Stock quote - … extended business tax return due datesWebDec 5, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to ... buc ee\u0027s tumblerWebJul 26, 2024 · Shares of Denali Therapeutics ( DNLI 0.36%) had sunk 11.2% as of 12:02 p.m. EDT on Monday. The decline came after the company presented interim results on Sunday from a phase 1/2 study evaluating ... buc ee\\u0027s travel center wisconsinWebApr 13, 2024 · Denali Therapeutics (DNLI) In a report released yesterday, Michael Yee from Jefferies maintained a Buy rating on Denali Therapeutics, with a price target of $50.00. The company’s shares closed ... extended butane lighter